International Seminar and Workshop on Fragile-X, Autism and Related Disorders Semarang, 7 August 2010 th Diponegoro University Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, UC Davis in collaboration with: Call for Poster Committee International Speakers Professor Randi Hagerman is a Developmental and Behavioral Pediatrician and the Medical Director of the M.I.N.D. Institute at UC Davis. She is internationally recognized as both a clinician and researcher in the fragile X field. Professor Hagerman received her M.D. from Stanford University where she also carried out her Pediatric residency. She completed a Fellowship in Learning and Disabilities and Ambulatory Pediatrics at UC San Diego and, subsequently, spent the next 20 years from 1980 to 2000 at the University of Colorado where she headed Developmental and Behavioral Pediatrics. She co-founded the National Fragile X Foundation in 1984 in Colorado and developed a world-renowned fragile X research and treatment center. In 2000, Professor Hagerman moved to UC Davis to be the Medical Director of the M.I.N.D. Institute. Dr. Hagerman and her team discovered the Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) which is a neurological disorder that affects older carriers of fragile X. Prof. Randi J. Hagerman, MD Louise Gane, M.Sc She is Senior Genetic Associate at the M.I.N.D. Institute. In 1991, she joined the team led by Dr. Hagerman at the Fragile X Research and Treatment Center in Denver, Colorado as a genetic counsellor. Under the directorship of Dr. Randi Hagerman, Louise is now located at the UC Davis M.I.N.D. Institute working as a Genetic Counsellor and Assistant to the Director. She is involved in counselling patients with Fragile X syndrome and their family members. In her role Louise helps families deal with and understand the diagnosis, assessing genetic risk, and explaining reproductive options Prof. Paul J. Hagerman, MD, PhD He received both his M.D. and Ph.D. degrees from Stanford University School of Medicine in 1977. This was followed by a three year Leukemia Society Fellowship at UCSD, where he began his studies of nucleic acid structure. He joined the University of Colorado in 1980, where he remained prior to joining the UC Davis faculty. Hagerman is currently on the scientific advisory board of the Muscular Dystrophy Association, and recently shifted toward the study of the Theme : 1. Abstracts may be submitted : [email protected] 2. All abstracts must be submitted and written in , maximum 3. Poster size: 90 x 120 cm (portrait) 4. Abstracts must contain neither published nor presented elsewhere and must be approved by all contributing authors. 5. Please structure your abstract using the following headings: Introduction, Objectives, Methods, Results, Conclusion. 6. Abstracts will be subject to 7. Deadline of abstract submission : and two weeks later, authors will be notified of acceptance by email. 8. Authors with accepted abstracts are entitled to register as participants. 9. Poster should be displayed by the participants in person prior the registration and should be standby during the Poster Session. Update on management and treatment of MR, Autism, and other Neurodevelopmental Disorder Guidelines for submission of abstracts: only via email English 250 words. original material blind peer reviewers. July 7, 2010 one hour molecular biology of neurodevelopmental disorders, with particular emphasis on fragile X syndrome, the leading heritable form of mental retardation. Since joining the Davis faculty, Dr. Hagerman has expanded his research efforts to include investigations of the underlying biochemical and genetic causes of autism. 2 nd Patron Chair Co-Chair Secretary Secretariat Treasurer Scientific Committee Talk show Committee Audiovisual & Documentation Accomodation Translator Rector of Diponegoro University Director of Dr Kariadi Hospital Semarang Dean, Faculty of Medicine Diponegoro University (FMDU) Vice Rector for Development and Cooperation Vice Dean for Finance Advisor of Center for Biomedical Research (Cebior) Prof. Sultana MH Faradz, MD, PhD Fitri Hartanto, MD (Pediatrician) Muflihatul Muniroh, MD, MSc Nani Maharani, MD, Msc, Ardina Aprilani, S.Sos Ratna Damma Purnawati, MD, Msc, Annastasia Ediati, S.Psi, MSc, Psi Asri Purwanti, MD (Pediatrician), Alifiani Hikmah Putranti, MD (Pediatrician), Dani Rahmawati, MD (Neurologist), Alifiati Fitrikasari, MD (Psychiatrist), Hexanto, MD (Neurologist), Eko Adhi Pangarsa, MD (Internist), Yetty Movieta Nency, MD (Pediatrician), Farmaditya EP Mundhofir, MD, Msc, Maria Belladona, MD, Rudi Handoyo, MD (Medical rehabilitation) Fitri Hartanto, MD (Pediatrician), Niken Puruhita, MD, MSc (Nutritionist) Agustini Utari, MD, MSc (Pediatrician), Costrie Ganes, SPsi Ahmad Zulfa Juniarto, MD, MSc (Andrologist) Aris Catur, MD (Neurologist) Widagdo, S.Ked Neni Susilaningsih, MD, Msc M. Mexitalia Setiawati, MD, PhD (Pediatrician), IDI Accredited
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
International Seminar andWorkshop on Fragile-X, Autism
and Related Disorders
Semarang, 7 August 2010th
Diponegoro University
Medical Investigation ofNeurodevelopmental Disorders
(MIND) Institute, UC Davis
in collaboration with:
Call for Poster
Committee
International Speakers
Professor Randi Hagerman is a Developmental and BehavioralPediatrician and the Medical Director of the M.I.N.D. Institute atUC Davis. She is internationally recognized as both a clinicianand researcher in the fragile X field. Professor Hagermanreceived her M.D. from Stanford University where she alsocarried out her Pediatric residency. She completed aFellowship in Learning and Disabilities andAmbulatory
Pediatrics at UC San Diego and, subsequently, spent the next 20 years from 1980 to 2000 atthe University of Colorado where she headed Developmental and Behavioral Pediatrics.She co-founded the National Fragile X Foundation in 1984 in Colorado and developed aworld-renowned fragile X research and treatment center. In 2000, Professor Hagermanmoved to UC Davis to be the Medical Director of the M.I.N.D. Institute. Dr. Hagerman andher team discovered the Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) which is aneurological disorder that affects older carriers of fragile X.
Prof. Randi J. Hagerman, MD
Louise Gane, M.ScShe is Senior Genetic Associate at the M.I.N.D. Institute. In 1991,she joined the team led by Dr. Hagerman at the Fragile XResearch and Treatment Center in Denver, Colorado as agenetic counsellor. Under the directorship of Dr. RandiHagerman, Louise is now located at the UC Davis M.I.N.D.Institute working as a Genetic Counsellor and Assistant to theDirector. She is involved in counselling patients with Fragile Xsyndrome and their family members. In her role Louise helps
families deal with and understand the diagnosis, assessing genetic risk, and explainingreproductive options
Prof. Paul J. Hagerman, MD, PhDHe received both his M.D. and Ph.D. degrees from StanfordUniversity School of Medicine in 1977. This was followed by athree year Leukemia Society Fellowship at UCSD, where hebegan his studies of nucleic acid structure. He joined theUniversity of Colorado in 1980, where he remained prior tojoining the UC Davis faculty. Hagerman is currently on thescientific advisory board of the Muscular DystrophyAssociation, and recently shifted toward the study of the
Theme :
1. A b s t r a c t s m a y b e s u b m i t t e d :[email protected]
2. All abstracts must be submitted and written in , maximum
3. Poster size: 90 x 120 cm (portrait)4. Abstracts must contain neither published nor
presented elsewhere and must be approved by all contributingauthors.
5. Please structure your abstract using the following headings:Introduction, Objectives, Methods, Results, Conclusion.
6. Abstracts will be subject to7. Deadline of abstract submission : and two weeks later,
authors will be notified of acceptance by email.8. Authors with accepted abstracts are entitled to register as
participants.9. Poster should be displayed by the participants in person
prior the registration and should be standby during the PosterSession.
Update on management and treatment of MR, Autism, andother Neurodevelopmental Disorder
Guidelines for submission of abstracts:o n l y v i a e m a i l
English 250words.
original material
blind peer reviewers.July 7, 2010
one hour
molecular biology of neurodevelopmental disorders, with particular emphasis on fragileX syndrome, the leading heritable form of mental retardation. Since joining the Davisfaculty, Dr. Hagerman has expanded his research efforts to include investigations of theunderlying biochemical and genetic causes of autism. 2nd
Patron
Chair
Co-Chair
Secretary
Secretariat
Treasurer
Scientific Committee
Talk show Committee
Audiovisual & Documentation
Accomodation
Translator
Rector of Diponegoro UniversityDirector of Dr Kariadi Hospital Semarang
Dean, Faculty of Medicine Diponegoro University (FMDU)Vice Rector for Development and Cooperation
Vice Dean for FinanceAdvisor of Center for Biomedical Research (Cebior)
Prof. Sultana MH Faradz, MD, PhD
Fitri Hartanto, MD (Pediatrician)
Muflihatul Muniroh, MD, MSc
Nani Maharani, MD, Msc, Ardina Aprilani, S.Sos
Ratna Damma Purnawati, MD, Msc, Annastasia Ediati, S.Psi, MSc, Psi
Asri Purwanti, MD (Pediatrician), Alifiani Hikmah Putranti, MD (Pediatrician),Dani Rahmawati, MD (Neurologist), Alifiati Fitrikasari, MD (Psychiatrist),
Hexanto, MD (Neurologist), Eko Adhi Pangarsa, MD (Internist),Yetty Movieta Nency, MD (Pediatrician), Farmaditya EP Mundhofir, MD, Msc,
Maria Belladona, MD,Rudi Handoyo, MD (Medical rehabilitation)
Fitri Hartanto, MD (Pediatrician), Niken Puruhita, MD, MSc (Nutritionist)Agustini Utari, MD, MSc (Pediatrician), Costrie Ganes, SPsi
Ahmad Zulfa Juniarto, MD, MSc (Andrologist)
Aris Catur, MD (Neurologist)
Widagdo, S.Ked
Neni Susilaningsih, MD, Msc
M. Mexitalia Setiawati, MD, PhD (Pediatrician),
ID
IAc
credit
ed
Background
Purpose
To disseminate recent advances and treatments in the fieldof Fragile X syndrome, Autism and related disorders fromthe expert scientist to the parents and people who areinterested in those field.
VenuePatra Convention HotelJl. Sisingamangaraja, Semarang
Participants
August, 7th 2010
Date
This workshop is suited for parents, students(undergraduates and postgraduates), medical scientists,clinicians, nutritionist, psychologist, and people who areinterested. The number of participants is limited to 300people.
Fragile-X syndrome (FXS) is the most common formof inherited intellectual disabilities (ID). The clinical signsare intellectual disabilities, hyperactive, autism,psychoneurologic disorders, and macroorchidism (testesenlargement) in male. The common affected is in males;however, carrier female could have a mild intellectualdisability such as learning difficulties, without othersymptoms. Some clinically normal males (NormalTransmitting Males) are known to carry and transmit thefragile X mutation to their daughter. In advance age, carriersof FXS could develop Fragile-X-Associated Tremor Ataxia(FXTAS), a neurodegenerative disorder.
Autistic spectrum disorder (ASD) involvesdevelopmental abnormalities in reciprocal socialinteraction, communication, and repetitive behavior. Somegenetic disorders associated with autism for example:Down Syndrome (DS), FXS and microdeletion chromosomaldisorders such as Angelman syndrome, Prader Willisyndrome etc. The information gap between experts andparents could be a serious problem for patientmanagement. Recently many studies in this field have beendeveloped to find the newest and effective treatment andmanagement.
Advances in understanding the neurobiology of FXShave led to new targeted treatments. The most remarkableare the metabotropic glutamate receptor 5 (mGluR5)antagonists. The mGluR5 antagonists have been studied inanimal models of fragile X and have been shown to have abeneficial effect on seizures, cognition, and behavior.Another recent advances in FXS treatment is Minocycline.Studies in animal models suggest that minocycline is notonly useful as an antibiotic but may also has potential asneuroprotective agent. Those advancements in FXStreatment in patients will be discussed in this workshop.
Within the framework of long collaboration with theMedical Investigation of Neurodevelopmental Disorders(MIND) Institute, UC Davis, USA; Faculty of MedicineDiponegoro University (FMDU) Semarang Indonesia willorganize a 2nd International workshop on Fragile XSyndrome, Autism and Related Disorders. This workshop
comprises also a talk show session, which will present somecases of autism and ID patients.
Information and registrationWiwik / Dina (Center for Biomedical Research)
GSG 2nd Floor Jl. Dr. Sutomo 14 SemarangTel: +62-24-8412311 Fax: +62-24-8454714
HP:+62-81-931980014e-mail :
[email protected] : www.cebior.co.cc
Registration FeeUNDIP staff FreeNon UNDIP staff
Discount 50% for autism parents, FMDU students andalumni of genetic counselling master program UNDIP.
Physician (Specialist) Rp. 500.000,-General Practitioner Rp. 250.000,-Public Rp. 250.000,-
Saturday, August 7, 201007.30 - 08.00 Registration
08.00 - 08.15 Opening Speech by :1. Chairperson2. Rector of Diponegoro University
08.15 – 08.30
08.30 - 08.50
08.50 – 09.20
09.20 - 09.50
09.50 – 10.20
10.20 – 10.35
Future and challenges of Autism Center inIndonesiaProf. Susilo Wibowo, MD, PhD, Andrologist
Fragile X syndrome in IndonesiaProf. Sultana MH Faradz, MD, PhDRNA toxicity and FXTAS in Fragile-Xpremutation carriersProf. Paul Hagerman, MD, PhDClinical Aspect of Autism and ItsManagementMelly Budhiman, MD, Child PsychiatristAutism and Fragile X syndrome: Advancesin Targeted treatmentsProf. Randi J. Hagerman, MD, PhDDiscussion
10.50 – 11.05
11.05 – 11.45
11.45 – 12.10
12.10 – 12.25
Minocycline study in Fragile X syndromeand AutismAgustini Utari, MD, M.Sc, PediatricianPsychopharmacological intervention inAutism and Fragile X syndromeProf. Randi J. Hagerman, MD, PhDGenetic Counseling in Fragile X syndromeand AutismLouise Gane, M.ScDiscussion
12.25 - 13.10 Lunch and poster session
13.10 – 15.20 Talk show (patients, parents andexperts)
15.20 - 15.40 Best posters announcement andClosing ceremony
Program
Related Documents
